Please share this announcement with individuals in the following roles:

  • CEO, COO, CNO, Chief Medical Officer
  • Quality Director
  • Infection Control Coordinator, Emergency Preparedness
    Coordinator, Accreditation Coordinator

CMS QSO-20-13 Guidance for Infection Control and Prevention of COVID-19 – Revised 

Key points:
CMS has waived a number of requirements under Section 1135 of the Social
Security Act for acute care hospitals (ACH), psychiatric hospitals, and critical
access hospitals (CAH). Links are provided throughout the revised memo to
various resources related to COVID-19 from the CDC and CMS.

Acute care hospitals have been following the CDC Prevention website for up-to-
date information and resources to mitigate COVID-19 transmission both
inpatient and outpatient. It is now recommended that psychiatric hospitals and
CAHs also monitor and use this website.

Information is available on how to plan for monitoring healthcare personnel for
exposure to known or suspected COVID-19 and guidance about when to allow
personnel to return to work following exposure.

Recommended measures and strategies for hospitals, psychiatric hospitals and
CAHs to help mitigate the transmission of COVID-19 in outpatient and inpatient
settings are provided.

In this publication, CMS addresses:

  1. Use of ACH excluded psychiatric and rehabilitation units to expand bed
    capacity
  2. Relocating patients of ACH excluded psychiatric and rehabilitation units
    to inpatient beds to temporarily expand bed capacity in these units
  3. Identification of which patients are at risk of COVID 19
  4. Recommendations on how and when to screen visitors, patients, and
    healthcare facility staff for COVID-19 and management of staff for
    exposure.
  5. Continued organ procurement and donations
  6. Recommendations of patient placement to maximize infection
    prevention and control
  7. Guidance on requiring or not requiring hospitalization for known or
    suspected COVID 19 patients
  8. Considerations and recommendations for diagnostic or therapeutic
    interventions for COVID-19, with updated information and links to CDCs
    recommended strategies to optimize the use of facemasks.
  9. Guidance for discontinuation of Transmission-Based Precautions
  10. Considerations for discharge to subsequent care locations, with special
    consideration for patients with psychiatric or cognitive disabilities.
  11. Implications of discharge planning regulations for patients with COVID-19
  12. Expansion of restrictions or limitation of visitors, including guidance on
    how to prevent the spread of COVID 19 with visitation.

Are any HFAP Standards affected?
This is provided for information only. If your organization is surveyed during the
COVID-19 pandemic, HFAP surveyors will survey the organization using the
most up to date CMS requirements and 1135 waivers approved for the
organization or state.

Effective date: March 30, 2020

Read CMS QSO-20-13 – Revised.